[非酒精性脂肪肝疾病的MDT管理]
1Department of Gastroenterology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
概括
非酒精性脂肪肝 (NAFLD) 是一种常见的肝脏疾病,与代谢问题有关. 本综述探讨了针对NAFLD的多学科团队 (MDT) 管理,旨在改善患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 临床管理 临床管理
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是最常见的慢性肝病.
- NAFLD与肥胖和代谢相关疾病如2型糖尿病,心血管,脑血管和慢性脏疾病密切相关.
- 纳氏脂肪炎的临床影响和严重程度正在逐渐增加.
研究的目的:
- 审查NAFLD多学科诊断和治疗 (MDT) 的理论基础.
- 探索MDT在NAFLD患者护理中的实际实施途径.
- 识别和讨论当前在应用MDT治疗NAFLD中的困境和挑战.
主要方法:
- 在NAFLD中对MDT的理论基础进行文献综述.
- 在NAFLD管理中分析MDT的实施策略.
- 检查目前对NAFLD的MDT方法中的挑战和局限性.
主要成果:
- MDT管理提供了一种有希望的方法来提高NAFLD预防和治疗效率.
- 在NAFLD中MDT的具体实施途径需要进一步调查和标准化.
- 现有的困境和挑战可能会阻碍MDT对NAFLD患者的最佳应用.
结论:
- 综合多维治疗是改善NAFLD护理的有价值的框架.
- 需要进一步的研究来完善对NAFLD的MDT实施.
- 解决已识别的挑战对于最大限度地发挥MDT在NAFLD管理中的好处至关重要.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Diseases of the Liver and Gallbladder
621
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
621
Ultrasound II: Endoscopic Ultrasound and FibroScan
136
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
136
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8


